Other News To Note
Monday, May 13, 2013
Oxygen Biotherapeutics Inc., of Morrisville, N.C., reported Friday that a 20-to-1 reverse stock split of its common stock is effective. The split was approved by the company's stockholders at a special meeting held on April 26 and was approved by the board on that same date.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.